Vanguard Group Inc Myriad Genetics Inc Put Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
234Shares Held
94.2MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$122 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$39.7 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$38.8 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$37 Million0.69% of portfolio
-
Morgan Stanley New York, NY4.55MShares$36.7 Million0.0% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $650M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...